Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.49B
Enterprise Value6.15B
P/E Ratio23.06
PEG Ratio-0.49
Price/Sales Ratio0.73
Price/Book Ratio1.02
Enterprise/Revenue1.34
Enterprise/EBITDA11.83

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.03
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.04

Income Statement

Revenue4.19B
Revenue/Share15.28
Gross Profit629.45M
EBITDA619.56M
Net Income200.3M
Diluted EPS0.66

Balance Sheet

Total Cash1.12B
Total Cash/Share3.77
Total Debt3.79B
Total Debt/Equity1.16
Current Ratio1.39
Book Value Per Share11

Price History

52-Week Change-37.35
52-Week High20.2
52-Week Low9.97
Moving Average 50 Days12.37
Moving Average 200 Days15.17

Statistics

Average Volume11.45M
Shares Outstanding298.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield4.48
Payout Ratio1.3
Last Split Factor13:10
Last Split DateMay 28, 2024
AD